Abstract
In 2007, sub-Saharan Africa was home to over half of all women living with HIV. The vast majority of these women are of reproductive age, which raises concerns about the high incidence of pregnancy. As access to antiretroviral treatment is rapidly scaled up, two important questions must be answered: (1) Does pregnancy impact HIV disease progression?; (2) Does pregnancy modify the highly active antiretroviral therapy (HAART) response on HIV disease progression? A systematic review of the biomedical literature was conducted and seven relevant studies were identified. To date, it appears that there is no effect of pregnancy on HIV disease progression. Furthermore, initial studies in high-income countries suggest that pregnancy may positively modify the HAART response. These findings, however, must be interpreted with caution as it remains unclear how other factors, such as adherence, may influence the relationship between pregnancy, HIV disease progression, and HAART.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burris, S., & Cameron, E. (2008). The case against criminalization of HIV transmission. Journal of the American Medical Association, 300(5), 578–581. doi:10.1001/jama.300.5.578.
Conde-Agudelo, A., Villar, J., & Lindheimer, M. (2008). Maternal infection and risk of preeclampsia: Systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 198(1), 7–22. doi:10.1016/j.ajog.2007.07.040.
Conference Summary Report. (2008). Switching gears in HIV research: Building an international research agenda on the impact of HAART on fertility in sub-Saharan Africa. Retrieved June 20, 2008, from http://www.phru.co.za/pdf/conference/joburg_conference_summary_report_may30_2008.pdf.
Dlamini, P. S., Kohi, T. W., Uys, L. R., Phetlhu, R. D., Chirwa, M. L., Naidoo, J. R., et al. (2007). Verbal and physical abuse and neglect as manifestations of HIV/AIDS stigma in five African countries. Public Health Nursing (Boston, Mass.), 24(5), 389–399. doi:10.1111/j.1525-1446.2007.00649.x.
Ekouevi, D. K., Inwoley, A., Tonwe-Gold, B., Danel, C., Becquet, R., Viho, I., et al. (2007). Variation of CD4 count and percentage during pregnancy and after delivery: Implications for HAART initiation in resource-limited settings. AIDS Research and Human Retroviruses, 23(12), 1469–1474. doi:10.1089/aid.2007.0059.
Eyakuze, C., Jones, D. A., Starrs, A. M., & Sorkin, N. (2008). From PMTCT to a more comprehensive AIDS response for women: A much-needed shift. Developing World Bioethics, 8(1), 33–42. doi:10.1111/j.1471-8847.2008.00230.x.
French, R., & Brocklehurst, P. (1998). The effect of pregnancy on survival in women infected with HIV: A systemic review of the literature and meta-analysis. International Journal of Obstetrics and Gynaecology, 105, 827–835.
Gottlieb, M. S. (2001). AIDS—past and future. The New England Journal of Medicine, 344(23), 1788–1791. doi:10.1056/NEJM200106073442312.
Gray, G., & McIntyre, J. (2007). HIV and pregnancy. British Medical Journal, 334, 950–953. doi:10.1136/bmj.39176.674977.AD.
Jansen van Rensburg, M. S. (2007). A comprehensive programme addressing HIV/AIDS and gender based violence. Journal on the Social Aspects of HIV/AIDS, 4(3), 695–706.
Karchar, H., Omondo, A., Odera, J., Kunz, A., & Harms, G. (2007). Risk factors for treatment denial and loss to follow-up in antiretroviral treatment in Kenya. Journal of Tropical Medicine and International Health, 12(5), 687–694.
Kourtis, A. P., Bansil, P., McPheeters, M., Meikle, S. F., Posner, S. F., & Jamieson, D. J. (2006). Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994–2003. AIDS (London, England), 21(16), 1823–1831.
Martin, F., Navaratne, L., Khan, W., Sarner, L., Mercey, D., Anderson, J., et al. (2006). Pregnant women with HIV infection can expect healthy survival: Three-year follow-up. Journal of Acquired Immune Deficiency Syndrome, 43(2), 186–192. doi:10.1097/01.qai.0000233311.28602.4d.
Mellins, C. A., Chu, C., Malee, K., Allison, S., Smith, R., Harris, L., et al. (2008). Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care, 20(8), 958–968. doi:10.1080/09540120701767208.
Minkoff, H., Hershow, R., Watts, H., Frederick, M., Cheng, I., & Tuomala, R. (2003). The relationship of pregnancy to human immunodeficiency virus disease progression. American Journal of Obstetrics and Gynecology, 189, 552–559. doi:10.1067/S0002-9378(03)00467-8.
Saada, M., Le Chenadec, J., & Berrebi, A. (2000). Pregnancy and progression to AIDS: Results of the French prospective cohorts. SEROGEST and SEROCO study groups. AIDS (London, England), 14, 2355–2360. doi:10.1097/00002030-200010200-00017.
Suy, A., Martínez, E., Coll, O., Lonca, M., Palacio, M., de Lazzari, E., et al. (2006). Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS (London, England), 20(1), 59–66. doi:10.1097/01.aids.0000198090.70325.bd.
Szyld, E. G., Warley, E. M., Freimanis, L., Gonin, R., Cahn, P. E., Calvet, G. A., et al. (2006). Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth. AIDS (London, England), 20(18), 2345–2353. doi:10.1097/01.aids.0000253362.01696.9d.
Tai, J. H., Udoji, M. A., Barkanic, G., Byrne, D. W., Rebeiro, P. F., Byram, B. R., et al. (2007). Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. The Journal of Infectious Diseases, 196(7), 1044–1052. doi:10.1086/520814.
The International Perinatal HIV Group. (1999). The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies. The New England Journal of Medicine, 340, 977–987. doi:10.1056/NEJM199904013401301.
Thorne, C., & Newell, M. L. (2007). Safety of agents used to prevent mother-to-child transmission of HIV: Is there any cause for concern? Drug Safety, 30(3), 203–213. doi:10.2165/00002018-200730030-00004.
Tuomala, R. E., Watts, D. H., Li, D., Vajaranant, M., Pitt, J., Hammill, H., et al. (2005). Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. Acquired Immune Deficiency Syndrome, 38(4), 449–473. doi:10.1097/01.qai.0000139398.38236.4d.
United Nations Joint Programme on HIV/AIDS. (2006). Report on the Global AIDS Epidemic 2006. Retrieved July 20, 2008, from http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/.
United Nations Joint Programme on HIV/AIDS. (2008). Report on the Global AIDS Epidemic 2008. Retrieved March 12, 2009, from http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp.
van Benthem, B. H., Vernazza, P., Coutinho, R. A., & Prins, M. (2002). European study on the natural history of HIV infection in women and the swiss HIV cohort study: The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS (London, England), 16(6), 919–924. doi:10.1097/00002030-200204120-00012.
World Bank. (2008). Country classification table (2008). Retrieved July 5, 2008, from http://go.worldbank.org/K2CKM78CC0.
World Health Organization. (2006). HIV and infant feeding: New evidence and programmatic experience: Report of a technical consultation held on behalf of the inter-agency task team (IATT) on prevention of HIV infections in pregnant women, mothers and their infants. Retrieved December 26, 2008, from http://whqlibdoc.who.int/publications/2007/9789241595971_eng.pdf.
World Health Organization. (2008). The global burden of disease: 2004 update. Retrieved February 1, 2009, from http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf.
World Health Organization and United Nations Programme on HIV/AIDS. (1999). HIV in pregnancy: A review. Retrieved September 13, 2008, from http://who.int/reproductive-health/publications/archive/rhr_99_15/index.html.
World Health Organization and United Nations Programme on HIV/AIDS. (2008). Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector: Progress report 2008. Retrieved July 20, 2008, from http://www.who.int/hiv/pub/towards_universal_access_report_2008.pdf.
Zorrilla, C. D., Santiagor, L. E., Knubson, D., Liberatore, K., Estronza, G., Colon, O., et al. (2003). Greater adherence to HAART between pregnant vs. non-pregnant women living with HIV. Cellular and Molecular Biology, 49(8), 1187–1192.
Acknowledgments
The authors are thankful to Carol Mita for her assistance in the design and review of the search strategy used in this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
MacCarthy, S., Laher, F., Nduna, M. et al. Responding to Her Question: A Review of the Influence of Pregnancy on HIV Disease Progression in the Context of Expanded Access to HAART in Sub-Saharan Africa. AIDS Behav 13 (Suppl 1), 66–71 (2009). https://doi.org/10.1007/s10461-009-9541-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-009-9541-2